JAK1 and liver dysplastic nodule: In brief, this study finds that DHI represses DR and DN advancement, and the mechanism is possibly achieved via elevated miR-30d-5p and targeting JAK1, offering a favorable basis for DHI therapy of DR and DN, and a new understanding and potentially useful target.